Organization
Biogen, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Biogen, Inc.
... effort that prioritized profits over public health (Purdue denies those allegations). (Reuters) Biogen spinal atrophy drug spurned by U.K.'s NICE. The U.K.'s drug pricing watchdog ...
... Biogen's spinal muscular atrophy drug Spinraza is pickingup steam in the U.S. and ...
... global autoinjectors market is dominated by Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). These players adopted growth strategies ...
... payments from partners, including $ 1 billion from Ionis' expanded collaboration with Biogen 'Our strong financial results were driven by a more than three-fold increase ...
... in payments from partners, including $1 billion from Ionis' expanded collaboration with Biogen On track for third consecutive year of pro forma operating profitability while ...
... the accumulation of sticky plaques. The new drug is BAN2401, designed by Biogen and Eisai to prevent those amyloid plaques from clustering and to attack ...
... Among the top 10 players in neurology, Biogen is the only company that generated more than 50% of its total ...
... PML in June, experts discussed a potential additive effect of Ocrevus to Biogen's Tysabri (natalizumab), though ultimately they concluded that the case was likely due ...
... Given the recent safety issues reported with AbbVie's and Biogen's Zinbryta (daclizumab), the companies have decided to voluntarily pull their recently launched ...
... from 2014 to 2016. With Sanofi's two recent acquisitions, Ablynx ($4.8B) and Biogenogen spin out Bioverativ ($11.6B) in January 2018, it begs the question, "Will ...
Subscribe now for full coverage on Biogen, Inc.
Start My Free Trial